ST
MYGN icon

Spot Trading’s Myriad Genetics MYGN Stock Holding History

Spot Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$152K Buy
4,200
+100
+2% +$2.85K ﹤0.01% 2381
2017
Q2 		$106K Buy
+4,100
New +$87K ﹤0.01% 2568
2016
Q4 		– Sell
-300
Closed -$6K – 3020
2016
Q3 		$6K Sell
300
-19,700
-99% -$500K ﹤0.01% 2932
2016
Q2 		$612K Buy
+20,000
New +$695K 0.01% 1471
2015
Q4 		– Sell
-7,100
Closed -$266K – 3898
2015
Q3 		$266K Buy
+7,100
New +$252K ﹤0.01% 2494
2015
Q2 		– Sell
-48,100
Closed -$1.7M – 4113
2015
Q1 		$1.7M Buy
48,100
+300
+0.6% +$10.7K 0.02% 1220
2014
Q4 		$1.63M Buy
47,800
+30,100
+170% +$1.07M 0.01% 1559
2014
Q3 		$683K Sell
17,700
-44,400
-71% -$1.66M ﹤0.01% 2345
2014
Q2 		$2.42M Sell
62,100
-107,600
-63% -$4M 0.01% 1497
2014
Q1 		$5.8M Sell
169,700
-99,500
-37% -$3.08M 0.03% 749
2013
Q4 		$5.65M Sell
269,200
-236,200
-47% -$5.97M 0.03% 773
2013
Q3 		$11.9M Buy
505,400
+276,300
+121% +$7.85M 0.07% 302
2013
Q2 		$6.16M Buy
+229,100
New +$6.64M 0.04% 600

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Spot Trading's MYGN Position: Q4 2016 in Review

Spot Trading sold out of Myriad Genetics (MYGN) in Q4 2016, closing a stake of 1,101 shares — an estimated $23K sold.

Spot Trading first reported a position in MYGN in Q3 2013 and held it in 8 quarters. The position peaked at $5.33M in Q3 2013. 223 funds tracked by Wall St. Rank hold MYGN as of Q4 2016.

  • Spot Trading reported no remaining Myriad Genetics position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 1,101 Myriad Genetics shares in Q4 2016, an estimated $23K.
  • Spot Trading first reported a position in Myriad Genetics in Q3 2013 and held it in 8 quarters.
  • Spot Trading's Myriad Genetics position peaked at $5.33M in Q3 2013.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.